Cosmo is responsible for strategy and business development, primarily matching unique business opportunities to the scientific advantages of the partnership. He is currently leading commercializations in the following areas: early detection, personalized medicine, genomics, advanced imaging, immunotherapy, microbiome and sustainable food supply.
Cosmo is involved at the early stages, working with scientists to design their vision based on unique intellectual property, helping growth-oriented companies achieve their next levels of success or larger entities utilize their existing infrastructure to capture new market share.
He was the Founder and CEO of United Advisors, a leading merchant bank focused on growth strategies and M&A. While at UA, he led the buildout of one of the fastest growing investment companies in the US, eventually listing on the NYSE.
Cosmo started his career with JP Morgan and received his MBA from the University of Connecticut.